VC  Pura Vida Investments

https://www.puravidainvestments.com/





     Office Locations:

150 East 52nd Street, Floor 32
New York, NY 10022
Phone: 646-757-2180

 

Stages:

  • Early


 

Industries:

  • Food & Agriculture
  • Information Technology
  • Life Sciences & Healthcare

  •  

    Description:

    Pura Vida is a healthcare-focused hedge fund with a market-neutral approach. Since inception, the firm has generated superior returns and was named Best Emerging Manager in Global Equities by Absolute Return in 2018. Pura Vida invests across the healthcare space, including medical technology and devices, biotechnology, pharmaceuticals, healthcare services, as well as the legal cannabis space. With nearly 100 collective years of experience investing in companies and operating companies, the majority of the team holds advanced degrees in medicine, science, and finance.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Doris Ting Heffernan Managing Director
    Efrem Kamen Managing Member
    Frank Litvack MD Member & Director of Designated Investments

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      07/29/2021


      Exo Imaging


      CA


      $220,000,000


      Series C


      04/07/2021


      Vizgen


      MA


      $37,000,000


      Series B


      01/13/2021


      Sensei Biotherapeutics


      MD


      $30,000,000


      Series B


     

    Portfolio companies include:

     

    Recent News: